EUVIMEDEUVIMED entdecken
VergleichsstudieÄquivalenzstudieMultizentrische StudieRandomisierte kontrollierte StudieOpen Access

YEARS Algorithm for Diagnosis of Suspected Pulmonary Embolism in Patients With Cancer

Bram Akerboom, Emily S L Martens, Milou A M Stals, Rolf E Brouwer, Michiel Coppens, Giorgio Costantino, Francis Couturaud, Yordi P A van Dooren, René van der Griend, Olivier Hugli, David Jiménez, Pieter W Kamphuisen und 19 weitere

JAMA · 25.08.2026 · 336 (8) · 655

DOI: 10.1001/jama.2026.10676 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift JAMA, erschienen am 25.08.2026. Verfasst von Bram Akerboom und 30 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine-Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, the Netherlands. Hauptthemen laut MEDLINE: Algorithms, Computed Tomography Angiography, Fibrin Fibrinogen Degradation Products, Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Although the YEARS algorithm is a safe and efficient way to rule out acute pulmonary embolism (PE), robust evidence on its accuracy in patients with cancer is lacking, and current guidelines suggest proceeding directly to computed tomographic pulmonary angiography (CTPA).

Objective

To compare the safety and efficiency of the YEARS algorithm with CTPA only to rule out acute PE in patients with active cancer. Design, Setting, and Participants The Hydra study was an open-label, randomized, investigator-initiated, noninferiority trial with blinded central outcome adjudication conducted from August 22, 2019, to August 21, 2025, the date of final follow-up. Patients with active cancer and suspected acute PE were recruited from emergency departments or medical units in 21 hospitals in the Netherlands, Italy, Switzerland, Belgium, France, and Spain.

Interventions

Patients were randomly assigned in a 1:1 ratio to receive diagnostic management by the YEARS algorithm (n = 352)—consisting of assessing YEARS items, D-dimer levels, and performing risk-dependent CTPA—or by CTPA only (n = 346). Main Outcomes and Measures The primary outcome was centrally adjudicated symptomatic venous thromboembolism or (possible) PE-related death within 90 days after ruling out PE at baseline, assessed in a per-protocol noninferiority analysis with a 2.6% margin for the upper bound of a 1-sided 99.9% CI. The key secondary outcome was the proportion of negative CTPA results at baseline, assessed in a superiority analysis.

Results

A total of 698 patients were randomized (median age, 65 years [IQR, 56-72 years], 422 female [60%]), and 104 patients (15%) had PE diagnosed at baseline. One patient was lost to follow-up. Of those in whom PE was considered excluded, 5 of 282 patients (1.8%) in the per-protocol YEARS group vs 15 of 273 patients (5.5%) in the per-protocol CTPA-only group had a primary outcome (absolute risk difference, −3.7%; 99.9% CI, −8.8% to 1.4%; P = 3.4 × 10 −5 for noninferiority). In the intention-to-diagnosis analysis, the absolute risk difference between the YEARS algorithm and CTPA only was −2.6% (99.9% CI, −7.5% to 2.4%; P = 5.9 × 10 −4 for noninferiority). Diagnostic management of PE was carried out for 77 of 352 patients (22%) in the YEARS group without CTPA. No difference in the proportion of negative CTPA ( P = .93) was observed between the groups. Conclusions and Relevance In patients with cancer and suspected PE, a diagnostic strategy using the YEARS diagnostic algorithm was as safe as using CTPA only, thus, obviating the need to perform CTPA in 22% of patients. Trial Registration ccmo.nl Identifier: NL-OMON52383

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AlgorithmsComputed Tomography AngiographyFibrin Fibrinogen Degradation ProductsNeoplasmsPulmonary EmbolismAgedFemaleHumansMaleMiddle AgedFollow-Up StudiesAcute DiseaseLung

Substanzen

Fibrin Fibrinogen Degradation Productsfibrin fragment D

Autor:innen und Institutionen

  • Department of Medicine-Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, the Netherlands.
  • Department of Internal Medicine, Reinier de Graaf Gasthuis, Delft, the Netherlands.
  • Department of Vascular Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
  • Pulmonary Hypertension & Critical Care, Amsterdam Cardiovascular Sciences, Amsterdam, the Netherlands.
  • Emergency Department, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Università degli Studi di Milano, Milan, Italy.
  • Department of Medicine and Pulmonology, CHU Brest, INSERM U1304-GETBO, Brest University, Brest, France.

Zitieren

APA

Akerboom, B., Martens, E. S. L., Stals, M. A. M., Brouwer, R. E., Coppens, M., Costantino, G., Couturaud, F., van Dooren, Y. P. A., van der Griend, R., Hugli, O., Jiménez, D., Kamphuisen, P. W., El Kharbouchi, O., Kroft, L. J. M., Leentjens, J., Maas, M. L., van Mens, T. E., Mahé, I., van Meer, O. A., …, & Hydra Study Investigators (2026). YEARS Algorithm for Diagnosis of Suspected Pulmonary Embolism in Patients With Cancer. JAMA, 336(8), 655. https://doi.org/10.1001/jama.2026.10676

Vancouver

Akerboom B, Martens ESL, Stals MAM, Brouwer RE, Coppens M, Costantino G, et al. YEARS Algorithm for Diagnosis of Suspected Pulmonary Embolism in Patients With Cancer. JAMA. 2026;336(8):655. doi:10.1001/jama.2026.10676

BibTeX
@article{Akerboom2026,
  author = {Akerboom, Bram and Martens, Emily S L and Stals, Milou A M and Brouwer, Rolf E and Coppens, Michiel and Costantino, Giorgio and Couturaud, Francis and van Dooren, Yordi P A and van der Griend, René and Hugli, Olivier and Jiménez, David and Kamphuisen, Pieter W and El Kharbouchi, Ouiam and Kroft, Lucia J M and Leentjens, Jenneke and Maas, Martje L and van Mens, Thijs E and Mahé, Isabelle and van Meer, Oene A and Out, Mattijs and Pola, Roberto and Raskin, Jo and Righini, Marc and Sprenger, Reinier A and Kaptein, Fleur H J and Talerico, Rosa and Tritschler, Tobias and Ten Wolde, Marije and Klok, Frederikus A and Huisman, Menno V and Hydra Study Investigators, Hydra Study Investigators},
  title = {YEARS Algorithm for Diagnosis of Suspected Pulmonary Embolism in Patients With Cancer},
  journal = {JAMA},
  year = {2026},
  volume = {336},
  number = {8},
  pages = {655},
  doi = {10.1001/jama.2026.10676}
}
Kostenlos starten →